Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: ACAN who wrote (22116)	1/24/2007 1:06:17 PM
From: Sergio H	Read Replies (2) \| Respond to of 23958

Acan....of interest on TSYS: Message 23212693 You mentioned playing the lottery or gambling the other day...along those lines, I took a bite of TRSI.pk :-)

To: ACAN who wrote (22116)	1/24/2007 2:12:21 PM
From: Galirayo	Read Replies (2) \| Respond to of 23958

[INGN] Is off and Running. siliconinvestor.com The new data were published in the journal Molecular Therapy. Introgen said the study showed that the combination of INGN 241 and Avastin was "very effective" and blocked tumor angiogenesis.